IPOPLUS

₹78.5

▲ +11.19 +16.62%

16 Jun 2026

NSE Listed · Pharmaceuticals

Valiant Laboratories Ltd. (VALIANTLAB)

Volume: 2,907Avg Vol 1W: 2,723Avg Vol 1M: 1,24652W Range:₹49.51₹124.4
NSE BSE
₹78.5▲ 16.62%
Key Ratios
Updated just now
Market Cap₹379 Cr
Current Price₹78.5
Previous Close₹67.31
High / Low (52w)₹124.4 / ₹49.51
Volume2,907
Avg Vol (1W)2,723
Avg Vol (1M)1,246
Stock P/E—
Book Value₹57.24
Dividend Yield0%
ROE-1.05%
ROA-0.71%
Revenue (TTM)—
Revenue Growth-26.74%
Profit Margin-1.38%
Total Debt₹104 Cr
Shares Outstanding5 Cr
Face Value₹10
EPS (TTM)₹0.32
P/B1.37
Debt / Equity0.15
50 DMA₹76.61
200 DMA₹64.51
Day change+16.62%
Price Chart
₹66.99▼ 18.57% · 1Y
₹97₹519.1L
2025-09-29
2026-06-16

20-day avg volume: 1K shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 28% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022
Revenue₹92 Cr₹52 Cr₹46 Cr₹47 Cr₹58 Cr₹35 Cr₹21 Cr₹19 Cr₹31 Cr₹41 Cr₹60 Cr₹51 Cr₹90 Cr₹71 Cr₹88 Cr
EBITDA₹2 Cr₹-2 Cr₹0 Cr₹3 Cr₹1 Cr₹2 Cr₹-4 Cr₹0 Cr₹-3 Cr₹-5 Cr₹1 Cr₹6 Cr₹10 Cr₹10 Cr₹12 Cr
Net Profit₹2 Cr₹-7 Cr₹0 Cr₹2 Cr₹1 Cr₹2 Cr₹-5 Cr₹-1 Cr₹-1 Cr₹-3 Cr₹1 Cr₹4 Cr₹8 Cr₹8 Cr₹9 Cr
EPS0.35-1.30.040.420.160.54-1.09-0.12-0.33-0.810.241.312.414.75.32
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Revenue₹139 Cr₹192 Cr₹339 Cr₹293 Cr₹184 Cr
EBITDA₹-1 Cr₹-1 Cr₹38 Cr₹42 Cr₹49 Cr
Net Profit₹-2 Cr₹0 Cr₹29 Cr₹27 Cr₹31 Cr
EPS-0.510.138.919.5210.83
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Total Assets₹401 Cr₹343 Cr₹213 Cr₹182 Cr₹106 Cr
Total Liabilities₹167 Cr₹106 Cr₹112 Cr₹110 Cr₹18 Cr
Equity₹234 Cr₹237 Cr₹100 Cr₹71 Cr₹89 Cr
Total Debt₹104 Cr₹75 Cr₹59 Cr₹59 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹-1 Cr₹1 Cr₹65 Cr₹17 Cr₹26 Cr
Investing₹-53 Cr₹-144 Cr₹-55 Cr₹-12 Cr₹-17 Cr
Financing₹45 Cr₹152 Cr₹-1 Cr₹6 Cr₹11 Cr
Free Cash Flow₹-1 Cr₹1 Cr₹65 Cr₹17 Cr₹26 Cr
Shareholding
Promoter 74.94% Institutions 0.2% Public 24.86%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search